Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026

Boston Scientific Corporation (NYSE:BSX) is included successful our database of the best low-risk high-reward stocks.

As portion of the firm’s Q1 preview for aesculapian exertion and beingness subject tools firms, Evercore ISI expert Vijay Kumar reduced the firm’s terms people connected Boston Scientific Corporation (NYSE:BSX) to $80 from $96 connected April 6, 2026, while maintaining an “Outperform” rating.

On March 30, 2026, pursuing the merchandise of the firm’s objective proceedings data, RBC Capital reaffirmed an “Outperform” standing and a $115 terms people for Boston Scientific. The steadfast expects 30% year-over-year maturation successful 2026, 10 percent points higher than absorption guidance. Thus, Boston Scientific remains a bully banal to buy.

Meanwhile, the company’s AsurysTM Fluid Management System came into the spotlight recently.

The system, intended to heighten irrigation and modulate intrarenal unit during urologic procedures similar ureteroscopy, received 510(k) clearance from the U.S. Food and Drug Administration. Boston Scientific Corporation (NYSE:BSX) announced this connected the aforesaid time arsenic RBC Capital’s update.

Based connected Boston Scientific Corporation (NYSE:BSX)’s unit data, the strategy whitethorn power fluid travel successful existent time, thereby reducing problems and enhancing workflow ratio and doc visualization. It besides allows scope-based irrigation power and integrated unit monitoring erstwhile utilized with the LithoVue Elite ureteroscope.

Despite much cautious near-term expert views, the motorboat expands Boston Scientific’s StoneSmart portfolio.

Boston Scientific Corporation (NYSE:BSX) is simply a planetary aesculapian exertion person that develops, manufactures, and markets less-invasive aesculapian devices utilized successful interventional specialties, including cardiology, peripheral interventions, electrophysiology, endoscopy, and urology. Their products, specified arsenic stents, pacemakers, and imaging systems, are utilized by healthcare professionals worldwide to diagnose and dainty assorted diseases.

While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.